Mark D McKee Selected Research

Mark D McKee Research Topics

Disease

12	Neoplasms (Cancer) 01/2018 - 01/2002
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 07/2014
3	Breast Neoplasms (Breast Cancer) 01/2020 - 08/2002
3	Melanoma (Melanoma, Malignant) 01/2017 - 03/2003
2	Triple Negative Breast Neoplasms 01/2020 - 01/2018
2	Hepatocellular Carcinoma (Hepatoma) 01/2015 - 05/2006
2	Thrombocytopenia (Thrombopenia) 09/2014 - 07/2014
1	Hereditary Angioedemas 02/2024
1	Angioedema 02/2024
1	Transthyretin-Related Hereditary Amyloidosis 01/2021
1	Amyloidosis 01/2021
1	Polyneuropathies (Polyneuropathy) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Anemia 01/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2015
1	Hematologic Neoplasms (Hematological Malignancy) 08/2015
1	Colorectal Neoplasms (Colorectal Cancer) 09/2014
1	Hypothyroidism 09/2014
1	Leukopenia 07/2014
1	Neutropenia 07/2014
1	Sarcoma (Soft Tissue Sarcoma) 06/2012
1	Lung Neoplasms (Lung Cancer) 06/2012
1	Hypertension (High Blood Pressure) 06/2012
1	Thymus Neoplasms (Thymus Neoplasm) 06/2012
1	Vitiligo 01/2010
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 12/2009
1	Persistent Infection 05/2006
1	Liver Failure 05/2006
1	Fibrosis (Cirrhosis) 05/2006
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2002

Drug/Important Bio-Agent (IBA)

6	linifanibIBA 11/2015 - 06/2012
5	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 07/2014
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 07/2014
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2015 - 07/2014
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 11/2015 - 07/2014
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018 - 01/2018
2	veliparibIBA 01/2018 - 01/2018
2	Phosphotransferases (Kinase)IBA 08/2015 - 07/2014
2	Monophenol Monooxygenase (Tyrosinase)IBA 12/2009 - 03/2003
2	AntigensIBA 12/2009 - 09/2005
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2005 - 03/2003
2	Peptides (Polypeptides)IBA 09/2005 - 03/2003
2	Interleukin-2 (IL2)IBA 03/2003 - 01/2002
1	Kallikreins (Kallikrein)IBA 02/2024
1	CRISPR-Associated Protein 9IBA 02/2024
1	Prealbumin (Transthyretin)IBA 01/2021
1	NTLA-2001IBA 01/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2018
1	PlatinumIBA 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018
1	Gemcitabine FDA Link 01/2018
1	omaveloxoloneIBA 01/2017
1	Alkaline PhosphataseIBA 01/2017
1	TriterpenesIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 11/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2015
1	ilorasertibIBA 08/2015
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2015
1	Aurora KinasesIBA 08/2015
1	Azacitidine (5 Azacytidine)FDA Link 08/2015
1	Platelet-Derived Growth FactorIBA 02/2015
1	Sorafenib (BAY 43-9006)FDA Link 01/2015
1	Bevacizumab (Avastin)FDA Link 09/2014
1	Phenol (Carbolic Acid)FDA Link 01/2010
1	Ether (Diethyl Ether)IBA 01/2010
1	hydroquinone (Esoterica)FDA Link 01/2010
1	Interferon-gamma (Interferon, gamma)IBA 12/2009
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2008
1	Antineoplastic Agents (Antineoplastics)IBA 04/2008
1	CAP1-6DIBA 04/2007
1	HLA-A Antigens (HLA-A)IBA 04/2007
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2007
1	Cancer VaccinesIBA 01/2007
1	Antiviral Agents (Antivirals)IBA 05/2006
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 03/2003

Therapy/Procedure

10	Therapeutics 02/2024 - 01/2002
2	Neoadjuvant Therapy 01/2020 - 01/2018
2	Immunotherapy 12/2009 - 01/2007
1	Drug Therapy (Chemotherapy) 01/2018
1	Transplantation 05/2006
1	Segmental Mastectomy (Lumpectomy) 08/2002